fcastell	10.1016/j.neuropharm.2007.04.016	<http://dx.doi.org/10.1016/j.neuropharm.2007.04.016>; rel="canonical", <https://api.elsevier.com/content/article/PII:S0028390807001244?httpAccept=text/xml>; version="vor"; type="text/xml"; rel="item", <https://api.elsevier.com/content/article/PII:S0028390807001244?httpAccept=text/plain>; version="vor"; type="text/plain"; rel="item", <https://www.elsevier.com/tdm/userlicense/1.0/>; version="tdm"; rel="license"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.neuropharm.2007.04.016"><j.0:publisher>Elsevier BV</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/francis-j-castellino-22nru9v05n3in"><j.3:name>Francis J. Castellino</j.3:name><j.3:familyName>Castellino</j.3:familyName><j.3:givenName>Francis J.</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.1016/j.neuropharm.2007.04.016</j.2:doi><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0028-3908"><owl:sameAs>urn:issn:0028-3908</owl:sameAs><j.0:title>Neuropharmacology</j.0:title><j.1:issn>0028-3908</j.1:issn><j.2:issn>0028-3908</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:volume>53</j.2:volume><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2007-07</j.0:date><j.0:title>Subtype-selective antagonism of N-methyl-d-aspartate receptor ion channels by synthetic conantokin peptides</j.0:title><owl:sameAs rdf:resource="info:doi/10.1016/j.neuropharm.2007.04.016"/><j.0:identifier>10.1016/j.neuropharm.2007.04.016</j.0:identifier><j.1:volume>53</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/mary-prorok-22nru9v05n3in"><j.3:name>Mary Prorok</j.3:name><j.3:familyName>Prorok</j.3:familyName><j.3:givenName>Mary</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>145</j.2:pageStart><j.1:doi>10.1016/j.neuropharm.2007.04.016</j.1:doi><j.1:endingPage>156</j.1:endingPage><j.1:startingPage>145</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/zhenyu-sheng-22nru9v05n3in"><j.3:name>Zhenyu Sheng</j.3:name><j.3:familyName>Sheng</j.3:familyName><j.3:givenName>Zhenyu</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>156</j.2:pageEnd><owl:sameAs rdf:resource="doi:10.1016/j.neuropharm.2007.04.016"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/qiuyun-dai-22nru9v05n3in"><j.3:name>Qiuyun Dai</j.3:name><j.3:familyName>Dai</j.3:familyName><j.3:givenName>Qiuyun</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
